Status:
COMPLETED
Cardiac Resynchronization Therapy in Congenital Heart Diseases With Systemic Right Ventricle
Lead Sponsor:
Paris Cardiovascular Research Center (Inserm U970)
Collaborating Sponsors:
Marie Lannelongue Hospital, Le Plessis Robinson, France
Clinique Pasteur Toulouse
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
Brief Summary
This study aims to analyze outcomes of patients with systemic right ventricle (SRV) implanted with Cardiac Resynchronization Therapy (CRT) systems and to compare the impact of CRT in SRV patients with...
Detailed Description
Heart failure is henceforth the main cause of death in adult patients with congenital heart disease (CHD). The number of affected patients is expected to continue to grow exponentially due to the impo...
Eligibility Criteria
Inclusion
- All patients with congenital heart disease and CRT device
Exclusion
- Patient's refusal
Key Trial Info
Start Date :
January 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT04842851
Start Date
January 1 2004
End Date
December 31 2020
Last Update
April 13 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.